Mammalian cell expression systems are widely used in the production of high-value recombinant proteins due to their ability to perform accurate protein folding, post-translational modification, and assembly. The XBioR™ Stainless Steel Bioreactor System provides a stable, controllable, and scalable culture environment for mammalian cell suspension culture, supporting the efficient production of recombinant therapeutic proteins, enzymes, growth factors, hormones, fusion proteins, and other biological products.
The system effectively solves the core pain points in recombinant protein production, such as low cell density, short culture cycle, insufficient oxygen supply, unstable process parameters, and low protein expression. Through optimized mechanical structure and intelligent control strategies, it creates a mild and uniform culture environment that maximizes cell viability and target protein expression.
The XBioR™ system adopts a low-shear, high-mixing impeller design to protect sensitive mammalian cells from mechanical damage while ensuring uniform mixing. The high-precision control of dissolved oxygen, pH, temperature, and nutrition supply supports long-term stable culture and high-density cell growth.
Efficient and controllable feeding strategies help maintain cell metabolism and prolong the protein expression period, thereby increasing the final protein yield. The system supports a variety of aeration modes to meet the oxygen demand of different cell lines at different growth stages, avoiding oxidative stress or hypoxia inhibition.
Full SIP/CIP functions, aseptic quick-connect interfaces, and enclosed sampling and harvest systems ensure aseptic safety throughout the process. The equipment design complies with cGMP and regulatory requirements, with complete documentation support for DQ, IQ, OQ, FAT, and SAT validation.
In addition, the system can be integrated with online analytical sensors to realize real-time monitoring and feedback control of key process parameters, which is conducive to realizing process optimization, quality by design (QbD), and improved process robustness.
For biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and research institutions, the XBioR™ bioreactor provides a highly reliable platform from laboratory process development to commercial-scale production. Its smooth scale-up performance reduces process transfer risks and shortens the time from research to market.
By improving protein expression yield, ensuring product quality stability, and simplifying operational processes, the system helps reduce overall production costs and enhance the market competitiveness of recombinant protein products.
Previous: Insect cell production